Compare IVVD & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | SNDL |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 386.3M |
| IPO Year | 2021 | 2019 |
| Metric | IVVD | SNDL |
|---|---|---|
| Price | $1.61 | $1.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $8.75 | $5.00 |
| AVG Volume (30 Days) | ★ 3.6M | 1.4M |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,426,000.00 | N/A |
| Revenue This Year | $147.67 | $6.09 |
| Revenue Next Year | $22.76 | $2.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.46 | $1.15 |
| 52 Week High | $3.07 | $2.89 |
| Indicator | IVVD | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 55.12 |
| Support Level | $1.41 | $1.44 |
| Resistance Level | $1.77 | $1.60 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 71.43 | 97.06 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.